Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 40, Issue 3, Pages 867-877Publisher
WILEY
DOI: 10.1002/eji.200939445
Keywords
Anergy; CD8(+) T cells; NF-kappa B pathway; Tolerance
Categories
Funding
- CIHR [62851]
- Canadian Diabetes Association
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
Ask authors/readers for more resources
Elucidating the signaling events that promote T-cell tolerance versus activation provides important insights for manipulating immunity in vivo. Previous studies have suggested that the absence of PKC theta results in the induction of anergy and that the balance between the induction of the transcription factors NFAT, AP1 and NF-kappa B plays a key role in determining whether T-cell anergy or activation is induced. Here, we examine whether Bcl-10 and specific family members of NF-kappa B act downstream of PKC theta to alter CD8(+) T-cell activation and/or anergy. We showed that T cells from mice deficient in c-Rel but not NF-kappa B1 (p50) have increased susceptibility to the induction of anergy, similar to T cells from PKC theta-deficient mice. Surprisingly T cells from Bcl-10-deficient mice showed a strikingly different phenotype to the PKC theta-deficient T cells, with a severe block in TCR-mediated activation. Furthermore, we have also shown that survival signals downstream of NF-kappa B, are uncoupled from signals that mediate T-cell anergy. These results suggest that c-Rel plays a critical role downstream of PKC theta in controlling CD8(+) T-cell anergy induction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available